Integer (ITGR) Stock Forecast, Price & News

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ITGR shares.
View ITGR analyst ratings or view top-rated stocks.

6 brokers have issued 1 year target prices for Integer's stock. Their ITGR share price forecasts range from $85.00 to $105.00. On average, they expect the company's share price to reach $93.83 in the next twelve months. This suggests a possible upside of 19.2% from the stock's current price.
View analysts price targets for ITGR or view top-rated stocks among Wall Street analysts.

Integer's stock was trading at $68.46 at the beginning of 2023. Since then, ITGR shares have increased by 15.0% and is now trading at $78.70.
View the best growth stocks for 2023 here.

Integer saw a decline in short interest in the month of August. As of August 15th, there was short interest totaling 2,260,000 shares, a decline of 5.8% from the July 31st total of 2,400,000 shares. Based on an average trading volume of 243,700 shares, the days-to-cover ratio is currently 9.3 days. Approximately 6.9% of the shares of the stock are short sold.
View Integer's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our ITGR earnings forecast.

Integer Holdings Co. (NYSE:ITGR) issued its quarterly earnings data on Thursday, July, 27th. The medical equipment provider reported $1.14 earnings per share for the quarter, topping analysts' consensus estimates of $0.99 by $0.15. The medical equipment provider had revenue of $400.04 million for the quarter, compared to analyst estimates of $367.05 million. Integer had a net margin of 4.77% and a trailing twelve-month return on equity of 9.67%.

ETFs with the largest weight of Integer (NYSE:ITGR) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), SPDR S&P 600 Small CapValue ETF (SLYV), iShares S&P Small-Cap 600 Value ETF (IJS), Vanguard S&P Small-Cap 600 Value ETF (VIOV), Xtrackers S&P SmallCap 600 ESG ETF (SMLE) and SPDR S&P 600 Small Cap ETF (SLY).iShares U.S. Medical Devices ETF (IHI).

Integer issued an update on its FY 2023 earnings guidance on Thursday, July, 27th. The company provided EPS guidance of $4.23-$4.42 for the period, compared to the consensus estimate of $4.15. The company issued revenue guidance of $1.53 billion-$1.55 billion, compared to the consensus revenue estimate of $1.50 billion.

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Integer's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.23%), Franklin Resources Inc. (6.79%), Dimensional Fund Advisors LP (6.33%), Victory Capital Management Inc. (4.50%), State Street Corp (4.07%) and Earnest Partners LLC (3.87%). Insiders that own company stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Donald J Spence, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic and Pamela G Bailey.
View institutional ownership trends.

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ITGR stock can currently be purchased for approximately $78.70.

Integer (NYSE:ITGR) has a market capitalization of $2.62 billion and generates $1.38 billion in revenue each year. The medical equipment provider earns $66.38 million in net income (profit) each year or $2.12 on an earnings per share basis.

The company employs 10,000 workers across the globe.

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The official website for the company is www.integer.net. The medical equipment provider can be reached via phone at (214) 618-5243, via email at ir@integer.net, or via fax at 716-759-5654.